However, as briefly mentioned and for various reasons, data on statistical significance versus placebo were not obtained for all of the GLP-1RAs
While early findings around GLP-1 drugs are encouraging, we strongly believe in the importance of thorough clinical testing to ensure both efficacy and safety before any treatment becomes widely available
Participants who reported food tasting sweeter after taking GLP-1s were twice as likely to report increased satiety, 67% more likely to report a reduction in appetite, and 85% more likely to report a reduction in food cravings
This matters for metabolic health on GLP-1 medications, where blood sugar management is already a priority
Injectables require additional supplies like syringes and Bacteriostatic Reconstitution Water (bac), which adds to the per-dose cost
We are looking forward to hearing from each one of you, welcome new and old customers contact us for future business relationships and mutual success